ArticleEuropean journal of hospital pharmacy : science and practice2022

Benefit versus toxicity risk of digoxin in patients with COVID-19.

Burcu Kelleci Cakir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.